132 related articles for article (PubMed ID: 32550547)
1. Upregulation of the long non-coding RNA CBR3-AS1 predicts tumor prognosis and contributes to breast cancer progression.
Xu L; Zhu H; Gao F; Tang Y; Zhu Y; Sun Z; Wang J
Gene X; 2019 Jun; 2():100014. PubMed ID: 32550547
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of the long non-coding RNA CBR3-AS1 predicts tumor prognosis and contributes to breast cancer progression.
Xu L; Zhu H; Gao F; Tang Y; Zhu Y; Sun Z; Wang J
Gene; 2019; 721S():100014. PubMed ID: 34530987
[TBL] [Abstract][Full Text] [Related]
3. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Zhang Y; Meng W; Cui H
Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker.
Torkashvand S; Basi A; Ajdarkosh H; Rakhshani N; Nafisi N; Mowla SJ; Moghadas A; Mohammadipour M; Karbalaie Niya MH
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2897-2902. PubMed ID: 34582659
[TBL] [Abstract][Full Text] [Related]
5. LncRNA CBR3-AS1 potentiates Wnt/β-catenin signaling to regulate lung adenocarcinoma cells proliferation, migration and invasion.
Hou M; Wu N; Yao L
Cancer Cell Int; 2021 Jan; 21(1):36. PubMed ID: 33422081
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA CBR3-AS1 Promotes Stem-like Properties and Oxaliplatin Resistance of Colorectal Cancer by Sponging miR-145-5p.
Xie L; Cui G; Li T
J Oncol; 2022; 2022():2260211. PubMed ID: 35466320
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer.
Huang W; Su X; Yan W; Kong Z; Wang D; Huang Y; Zhai Q; Zhang X; Wu H; Li Y; Li T; Wan X
Prostate; 2018 Dec; 78(16):1248-1261. PubMed ID: 30105831
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-CBR3-AS1 promotes and enhances the malignancy of ulcerative colitis via targeting miRNA-145-5p/FN1.
Cao J; Zhao Q; Jia Q; Li Y
Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):181-186. PubMed ID: 37715388
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
10. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
11. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
Ma D; Chen C; Wu J; Wang H; Wu D
Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
[TBL] [Abstract][Full Text] [Related]
12. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
13. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Tuo Z; Zhang J; Xue W
Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
[TBL] [Abstract][Full Text] [Related]
14. LncRNA CCND2-AS1 is up-regulated and regulates proliferation, migration, and invasion in breast cancer.
Chen C; Xia E; Bhandari A; Wang Y; Shen Y; Sindan N; Lin Y; Wang X; Yang F; Wang O
Int J Clin Exp Pathol; 2018; 11(3):1453-1459. PubMed ID: 31938243
[TBL] [Abstract][Full Text] [Related]
15. CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4.
Zhang Y; Zhang H; Zhang X; Liu B
Dis Markers; 2022; 2022():7155525. PubMed ID: 35655916
[TBL] [Abstract][Full Text] [Related]
16. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer.
Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K
Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
19. AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer.
Zhang K; Liu P; Tang H; Xie X; Kong Y; Song C; Qiu X; Xiao X
Front Pharmacol; 2018; 9():1248. PubMed ID: 30505272
[TBL] [Abstract][Full Text] [Related]
20. Identification of long noncoding RNAs downregulated specifically in ovarian high-grade serous carcinoma.
Hayashi-Okada M; Sato S; Nakashima K; Sakai T; Tamehisa T; Kajimura T; Tamura I; Sueoka K; Sugino N
Reprod Med Biol; 2024; 23(1):e12572. PubMed ID: 38571514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
